Detournay B - Search Results

1

Insulin therapy for diabetes mellitus: treatment regimens and associated costs.

Charbonnel B, Penfornis A, Varroud-Vial M, Kusnik-Joinville O, Detournay B. Charbonnel B, et al. Among authors: detournay b. Diabetes Metab. 2012 Apr;38(2):156-63. doi: 10.1016/j.diabet.2011.10.003. Epub 2011 Dec 14. Diabetes Metab. 2012. PMID: 22172400

2

Parcours de soins, vers la mise en place d’un financement adapté : raisons et conditions de réussite.

Emery G, Le Fur C, Epis-de-Fleurian AA, Josseran A; les participants à la table ronde “Médico-économie” des Ateliers de Giens XXXIII. Emery G, et al. Therapie. 2018 Feb;73(1):25-32. doi: 10.1016/j.therap.2017.12.002. Epub 2017 Dec 16. Therapie. 2018. PMID: 29325756 French. No abstract available.

3

Télésurveillance et expérimentations ETAPES. Quelle pérennité après 2021 : quel modèle organisationnel et financement ?

le Douarin Y, Traversino Y, Graciet A, Josseran A; et les participants à la table ronde 'Santé et économie' des Ateliers de Giens XXXV. le Douarin Y, et al. Therapie. 2020 Jan-Feb;75(1):29-42. doi: 10.1016/j.therap.2019.11.003. Epub 2019 Dec 13. Therapie. 2020. PMID: 31959354 French. No abstract available.

4

Quel impact budgétaire pour l’arrivée d’un nouveau traitement ou d’une nouvelle technologie de santé ?

Dervaux B, Le Fur C, Dubois S, Josseran A; les participants à la table ronde n(o) 3 de Giens XXXIII. Dervaux B, et al. Therapie. 2017 Feb;72(1):81-91. doi: 10.1016/j.therap.2016.12.002. Epub 2016 Dec 31. Therapie. 2017. PMID: 28126190 French. No abstract available.

5

[Epidemiology, management and costs of type 2 diabetes in France in 1998].

Detournay B, Vauzelle-Kervroedan F, Charles MA, Forhan A, Fagnani F, Fender P, Eschwege E. Detournay B, et al. Diabetes Metab. 1999 Sep;25(4):356-65. Diabetes Metab. 1999. PMID: 10566128 Review. French.

6

[Medical resources consumption of type 2 diabetics in France in 1998].

Detournay B, Fagnani F, Pribil C, Eschwège E. Detournay B, et al. Diabetes Metab. 2000 May;26(3):225-31. Diabetes Metab. 2000. PMID: 10880898 French.

7

Managing type 2 diabetes in France: the ECODIA survey.

Detournay B, Cros S, Charbonnel B, Grimaldi A, Liard F, Cogneau J, Fagnani F, Eschwège E. Detournay B, et al. Diabetes Metab. 2000 Nov;26(5):363-9. Diabetes Metab. 2000. PMID: 11119015

8

Epidemiology and costs of diabetes treated with insulin in France.

Detournay B, Raccah D, Cadilhac M, Eschwège E. Detournay B, et al. Diabetes Metab. 2005 Jun;31(3 Pt 2):3-18. Diabetes Metab. 2005. PMID: 16142041 Clinical Trial.

9

Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: the ENTRED study 2001.

Romon I, Fosse S, Eschwège E, Simon D, Weill A, Varroud-Vial M, Detournay B, Fagot-Campagna A. Romon I, et al. Among authors: detournay b. Diabetes Metab. 2008 Apr;34(2):140-7. doi: 10.1016/j.diabet.2007.11.002. Epub 2008 Mar 4. Diabetes Metab. 2008. PMID: 18304854

10

Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study.

Bringer J, Fontaine P, Detournay B, Nachit-Ouinekh F, Brami G, Eschwege E. Bringer J, et al. Among authors: detournay b. Diabetes Metab. 2009 Feb;35(1):25-31. doi: 10.1016/j.diabet.2008.06.004. Epub 2008 Nov 28. Diabetes Metab. 2009. PMID: 19046913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters